Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Neoplasms × Routinely Collected Health Data × 90 days × Clear all

Sponsor

Interventions

Magnetic Resonance Spectroscopy 4 pembrolizumab 3 lenvatinib 3 trametinib 2 selpercatinib 2 anlotinib 2 Therapeutics 2 Specimen Handling 2 Nivolumab 2 Iodine-131 2 Iodine-124 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Biopsy, Fine-Needle 2 Biopsy 2 ulixertinib 1 tremelimumab 1 trastuzumab deruxtecan 1 pralsetinib 1 naporafenib 1 gallium Ga 68 dotatate 1 fludarabine phosphate 1 durvalumab 1 defactinib 1 dabrafenib 1 cobimetinib 1 binimetinib 1 atezolizumab 1 Watchful Waiting 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡